𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Millennium Cell and Protonex sign joint development and licensing agreement


Publisher
Elsevier Science
Year
2004
Weight
62 KB
Volume
2004
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

✦ Synopsis


turnover of $2005 M ($1842 M for its fiscal 2002), of which: Davison Chemicals (catalysts and silica) $1040 M ($939 M), performance chemicals $941 M ($880 M), North America $883 M ($883 M), Europe $677 M ($561 M), Asia Pacific $313 M ($269 M), and Latin America $108 M $107 M), R&D costs of $52 M ($51.5 M), capital investments of $86.4 M ($91.1 M), a net loss of $42.2 M (a net profit of $22.1 M), and a loss per share of $0.64 (EPS of $0.34). There is a detailed discussion of the results.